
Sign up to save your podcasts
Or
Description: Dr. Jasmin Jo interviews Dr. Michael Lim about his and his team's recent manuscript entitled: "Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter", published online in Neuro-Oncology in November 2022.
4.8
1212 ratings
Description: Dr. Jasmin Jo interviews Dr. Michael Lim about his and his team's recent manuscript entitled: "Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter", published online in Neuro-Oncology in November 2022.
7,685 Listeners
414 Listeners
32,043 Listeners
110,932 Listeners
55,862 Listeners
21 Listeners
26 Listeners
111 Listeners
12,488 Listeners
15,333 Listeners
10,233 Listeners
40 Listeners
25 Listeners
4 Listeners
38 Listeners